S100B Protein Study for Fetal Growth Restriction
Cord Blood S100B Protein Concentration in Neonates With Fetal Growth Restriction
Recruiting
Observational Study
s100b
Hypoxia-Ischemia, Brain
Fetal Growth Restriction (FGR)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 120 (estimated)
- Sponsor
- Institute of Mother and Child, Warsaw, Poland · Other
Who this trial is looking for
This trial is looking for pregnant women who are at least 37 weeks along, either with a diagnosis of fetal growth restriction or with normal growth. Participants will provide cord blood samples after delivery for analysis of certain proteins and other health indicators.
Are You a Good Fit for This Trial?
You may be able to join if
- I am at least 37 weeks pregnant.
- I am having a single baby.
You may not be able to join if
- I have conditions affecting blood flow in the placenta.
- I smoke or use illicit substances.
- I have been treated for depression with medication.
- I have signs of infection during labor.
- I have had prolonged labor lasting more than 15 hours.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
S100B protein is a biomarker that increases following central nervous system (CNS) damage. Measuring this protein's levels may allow for the early identification of infants at high risk for developmental abnormalities, such as fetal growth restriction (FGR), even on the first day of life, in a non-invasive manner. Early detection could enable timely interventions and rehabilitation, potentially im…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Study Group - Inclusion Criteria:
1. Women with a full-term pregnancy (≥37 weeks of gestation), singleton.
2. Pregnancy complicated by FGR.
Study Group - Exclusion Criteria:
1. Antenatal (at recruitment):
* Maternal conditions that may affect the blood flow in placental vessels, including smo…
Contacts